基层医院急性ST段抬高性心肌梗死临床路径应用费用增加原因初探  

On increasing cost of clinical pathways application in acute ST-elevation myocardial infarction at the grassroots level hospital

作　　者：安永为[1] 张学功[1] 耿学藩[1] 隗和红[1] 

机构地区：[1]北京市房山区第一医院心内科,北京102400

出　　处：《实用临床医药杂志》2011年第10期21-22,27,共3页Journal of Clinical Medicine in Practice

摘　　要：目的探讨急性ST段抬高心肌梗死临床路径在基层医院应用。方法 436例ST段抬高心肌梗死患者分为观察组和对照组,比较观察组和对照组住院费用和患者的满意度。结果临床路径未能有效减少基层住院费用,但提高了观察组住院患者的满意度。结论临床路径能释放基层医院需求,提高患者及家属满意度。Objective To explore the application of clinical pathway in the ST-elevation myocardial infarction（STEMI） at grassroots level hospital.Methods 436 ST-elevation myocardial infarction patients were divided into the observation group and the control group.The hospitalization expenses and patients′ satisfaction degree of both the observation group and the control group were compared.Results The clinical pathway was not effective in reducing hospital costs.However,patients and their family members were more satisfied with treatment in the observation group.Conclusion Application of clinical pathway can release the patients′ needs at grassroots level hospital and increase the satisfaction degree of patients and their family members.

关 键 词：临床路径 急性ST段抬高心肌梗死 住院费用 

分 类 号：R473.5[医药卫生—护理学]